Christelle Ferrá - Concepedia

Author

Christelle Ferrá

Also Known As

Bibiana Quirant, C Ferra, C Ferrà, C Ferrá, C. Ferra, C. Ferrà, C. Ferrá, Carlos Francisco Ramos Ferra, Carlos Solano, Christelle Ferra

177

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Hospital de Sant Pau Institut Català d'Oncologia Hospital Universitari Germans Trias i Pujol Hospital Clínico Universitario de Valencia Vall d'Hebron Hospital Universitari

About

Christelle Ferrá is an author at Hospital de Sant Pau specializing in medicine, hematology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	23	1K
2	Blood Transplantation	11	11	638
3	Health Sciences	5	5	246
4	Allergy	1	1	10
5	Biomedical Engineering	1	1	13

Christelle Ferrá

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease Nicolaus Kröger, Carlos Solano, Christine Wolschke, New England Journal of Medicine	2016	541
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia Roel Willemze, Celso Arrais‐Rodrigues, Myriam Labopin, Leukemia TransplantationMarrow TransplantationMedicineStem Cell TransplantationImmunology	2009	243
Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival David Valcárcel, Rodrigo Martino, Dolores Caballero, Journal of Clinical Oncology	2007	231
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy Joerg Halter, W. Michael, Michaël Schüpbach, Brain	2015	141
Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen Jaime Sanz, Juan Carlos Hernández‐Boluda, Carmen Martín, Bone Marrow Transplantation Hematological MalignancyUnrelated DonorsTransplantationMarrow TransplantationOncology	2012	137
Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia Francesc Bosch, Pau Abrisqueta, Neus Villamor, Journal of Clinical Oncology	2009	127
Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia Cristina Prat, Juan‐Manuel Sancho, José Domínguez, Leukemia & lymphoma/Leukemia and lymphoma	2008	117
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings Álvaro Urbano-Ispizúa, C Rozmán, Pedro Pimentel, Blood	2002	77
Outcome and Prognostic Factors in Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: A Single-Center Experience Christelle Ferrá, Pilar Marcos, Maite Misis, International Journal of Hematology Critical Care ManagementPrognostic FactorsCritical Care MedicineHematological MalignancyIntensive Care Unit	2007	70
Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide Albert Esquirol, María Pascual, Mi Kwon, Bone Marrow Transplantation TransplantationMarrow TransplantationSevere InfectionsInfection-related MortalityLarge Series	2021	69

Page 1